These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37670275)

  • 1. Identification and validation of a novel prognosis model based on m5C-related long non-coding RNAs in colorectal cancer.
    Di Z; Xu G; Ding Z; Li C; Song J; Huang G; Zheng J; Zhang X; Xiong B
    Cancer Cell Int; 2023 Sep; 23(1):196. PubMed ID: 37670275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. m5C-Related lncRNAs Predict Overall Survival of Patients and Regulate the Tumor Immune Microenvironment in Lung Adenocarcinoma.
    Pan J; Huang Z; Xu Y
    Front Cell Dev Biol; 2021; 9():671821. PubMed ID: 34268304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Risk Model and Tumor Immune Environment Modulation of m5C-Related LncRNAs in Pancreatic Ductal Adenocarcinoma.
    Yuan H; Liu J; Zhao L; Wu P; Chen G; Chen Q; Shen P; Yang T; Fan S; Xiao B; Jiang K
    Front Immunol; 2021; 12():800268. PubMed ID: 34956238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Value of m5C-Related lncRNAs in the Prognostic Assessment and Immunotherapy of Stomach Adenocarcinoma.
    He C; Zhu X; Kong F; Zhang X; Chai X; Zou C; Zhao D
    Biomed Res Int; 2022; 2022():2747799. PubMed ID: 35711526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of m5C-Related lncRNAs in the prognosis and immune landscape of hepatocellular carcinoma.
    Lu Q; Liu L; Wang S; Zhang Q; Li L
    Front Genet; 2022; 13():990594. PubMed ID: 36339006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of Prognostic Risk Model of 5-Methylcytosine-Related Long Non-Coding RNAs and Evaluation of the Characteristics of Tumor-Infiltrating Immune Cells in Breast Cancer.
    Huang Z; Li J; Chen J; Chen D
    Front Genet; 2021; 12():748279. PubMed ID: 34777473
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of the expression and prognostic significance of m
    Xu G; Li C; Di Z; Yang Y; Liang L; Yuan Q; Yang Q; Dong X; Xu S; Wu G
    Cancer Med; 2023 Mar; 12(6):7667-7681. PubMed ID: 36464884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
    Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
    Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer.
    Xiong X; Chen C; Li X; Yang J; Zhang W; Wang X; Zhang H; Peng M; Li L; Luo P
    Front Oncol; 2023; 13():972558. PubMed ID: 37064115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overall Survival Signature of 5-Methylcytosine Regulators Related Long Non-Coding RNA in Hepatocellular Carcinoma.
    Pan Q; Yi C; Zhang Y
    Front Oncol; 2022; 12():884377. PubMed ID: 35686101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value and immune landscaps of m6A/m5C-related lncRNAs signature in the low grade glioma.
    Li R; Chen H; Li C; Qi Y; Zhao K; Wang J; You C; Huang H
    BMC Bioinformatics; 2023 Jul; 24(1):274. PubMed ID: 37403043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M5C-Related lncRNA Predicts Lung Adenocarcinoma and Tumor Microenvironment Remodeling: Computational Biology and Basic Science.
    Bai M; Sun C
    Front Cell Dev Biol; 2022; 10():885568. PubMed ID: 35592248
    [No Abstract]   [Full Text] [Related]  

  • 13. 5-Methylcytosine RNA Methyltransferases-Related Long Non-coding RNA to Develop and Validate Biochemical Recurrence Signature in Prostate Cancer.
    Wang K; Zhong W; Long Z; Guo Y; Zhong C; Yang T; Wang S; Lai H; Lu J; Zheng P; Mao X
    Front Mol Biosci; 2021; 8():775304. PubMed ID: 34926580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
    Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
    Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel senescence-associated LncRNA signature predicts the prognosis and tumor microenvironment of patients with colorectal cancer: a bioinformatics analysis.
    Huang E; Ma T; Zhou J; Ma N; Yang W; Liu C; Hou Z; Chen S; Zong Z; Zeng B; Li Y; Zhou T
    J Gastrointest Oncol; 2022 Aug; 13(4):1842-1863. PubMed ID: 36092325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel methylation-related long non-coding RNA clinical outcome prediction method: the clinical phenotype and immune infiltration research in low-grade gliomas.
    Li Y; Li X; Yu Z
    Front Oncol; 2023; 13():1177120. PubMed ID: 37228500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.
    Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z
    Front Immunol; 2022; 13():951455. PubMed ID: 36189298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel prognostic signature based on cuproptosis-related lncRNA mining in colorectal cancer.
    Hou D; Tan JN; Zhou SN; Yang X; Zhang ZH; Zhong GY; Zhong L; Yang B; Han FH
    Front Genet; 2022; 13():969845. PubMed ID: 36105091
    [No Abstract]   [Full Text] [Related]  

  • 19. The prognostic value and immune landscapes of m1A/m5C/m6A-associated lncRNA signature in osteosarcoma.
    Wu ZY; Shi ZY
    Eur Rev Med Pharmacol Sci; 2022 Aug; 26(16):5868-5883. PubMed ID: 36066162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a Prognostic Colorectal Cancer Model Including LncRNA FOXP4-AS1 and LncRNA BBOX1-AS1 Based on Bioinformatics Analysis.
    Shi ZL; Zhou GQ; Guo J; Yang XL; Yu C; Shen CL; Zhu XG
    Cancer Biother Radiopharm; 2022 Dec; 37(10):893-906. PubMed ID: 33481661
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.